Finally, DeWilde explored future developments in anti-VEGF treatment, including biosimilars, implantable devices like Susvimo, and potential new delivery methods such as eye drops. He emphasized ...

The primary clinical target of our VEGF-specific antibody programs was cancer ... losing their ability to detect <15 letters on the eye chart compared with 62% in the sham injection group ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

Dr. Tolentino pioneered anti-VEGF eye injections, invented the first gene silencing therapeutic, and cracked the sugar immune code to transform destructive inflammatory cells into healing ones.

New treatments for macular degeneration may help preserve your eyesight for longer, without the need for frequent injections. Some of these treatments include retinal gene therapy and the "port ...

Physicians’ Education Resource (PER) has launched Retina Resource, a comprehensive source of education and information on the ...

For wet AMD, you can slow or stop symptoms and possibly reverse vision changes with anti-VEGF injections. Find out how wet AMD can affect vision loss and your eye health. AMD is a common age ...

Susvimo is indicated for intravitreal use via the Susvimo eye implant only. Ranibizumab is a vascular endothelial growth factor (VEGF) inhibitor designed to bind to and inhibit VEGF-A, a protein ...

Physicians’ Education Resource (PER ®) is excited to announce the launch of Retina Resource, a comprehensive source of cutting-edge education and information on the latest innovations in anti-VEGF ...

Ixo-vec is a potential best-in-class one-time gene therapy designed to deliver long-term efficacy, reduce the burden of frequent anti-VEGF and ...